anmelden
BX Swiss TOP 30 CHF
1.485,60
PKT
-2,98
PKT
-0,20
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.08.17 | Holcim Neutral | UBS AG | |
| 11.08.17 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 11.08.17 | Zurich Insurance Conviction Buy | Goldman Sachs Group Inc. | |
| 11.08.17 | UBS buy | HSBC | |
| 11.08.17 | Givaudan Underweight | Barclays Capital | |
| 11.08.17 | UBS buy | HSBC | |
| 11.08.17 | UBS buy | Goldman Sachs Group Inc. | |
| 10.08.17 | Zurich Insurance Hold | S&P Capital IQ | |
| 10.08.17 | Zurich Insurance Neutral | UBS AG | |
| 10.08.17 | UBS buy | Citigroup Corp. | |
| 10.08.17 | UBS buy | Citigroup Corp. | |
| 09.08.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 08.08.17 | Nestlé overweight | JP Morgan Chase & Co. | |
| 08.08.17 | Givaudan overweight | JP Morgan Chase & Co. | |
| 08.08.17 | Holcim Neutral | JP Morgan Chase & Co. | |
| 08.08.17 | Holcim buy | Citigroup Corp. | |
| 08.08.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.08.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 07.08.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 07.08.17 | UBS neutral | RBC Capital Markets | |
| 07.08.17 | Swiss Re buy | Goldman Sachs Group Inc. | |
| 07.08.17 | Swiss Re kaufen | DZ BANK | |
| 07.08.17 | Swiss Re Sell | UBS AG | |
| 07.08.17 | Swiss Re buy | Deutsche Bank AG | |
| 04.08.17 | Novartis buy | Baader Bank | |
| 04.08.17 | Swiss Re Sell | UBS AG | |
| 04.08.17 | Swiss Re Hold | S&P Capital IQ | |
| 04.08.17 | Swiss Re Reduce | Commerzbank AG | |
| 04.08.17 | Swiss Re Hold | Baader Bank | |
| 04.08.17 | Swiss Re Outperform | RBC Capital Markets | |
| 04.08.17 | Swiss Re market-perform | Bernstein Research | |
| 03.08.17 | Nestlé buy | Citigroup Corp. | |
| 03.08.17 | Holcim Hold | Deutsche Bank AG | |
| 03.08.17 | UBS buy | Deutsche Bank AG | |
| 01.08.17 | UBS buy | Citigroup Corp. | |
| 01.08.17 | UBS overweight | JP Morgan Chase & Co. | |
| 01.08.17 | UBS overweight | JP Morgan Chase & Co. | |
| 01.08.17 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 31.07.17 | Roche overweight | JP Morgan Chase & Co. | |
| 31.07.17 | UBS Neutral | Credit Suisse Group |